The recent introduction of fluoride or gallium-labelled prostate-specific membrane antigen (PSMA) radiotracers in functional imaging with PET/CT has added an important diagnostic tool, which has revolutionized prostate cancer management. Here, FOLH1 is linked to prostate carcinoma.